Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-04
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
CD28–ARS2 Control of CD8+ T Cell Metabolism
2026-08-22
The reference study identifies a CD28–ARS2 signaling axis that reshapes alternative splicing of PKM in activated CD8+ T cells, favoring PKM2 and enabling flexible glucose utilization. Its findings connect costimulatory signaling to RNA processing, cytokine production, and antitumor activity through a mechanism that is distinct from canonical PI3K signaling.
-
Protein A/G Magnetic Co-IP/IP Kit for PINK1
2026-08-21
Translate UBC9–PINK1 biology into reproducible co-IP, western blot, and mass spectrometry workflows with magnetic separation and Fc-selective capture. This guide combines an application-focused protocol with controls, optimization ranges, and troubleshooting for protein-complex isolation and antibody purification.
-
Cy3 Goat Anti-Human IgG (H+L) Antibody Workflow
2026-08-20
Build reproducible human IgG detection workflows for immunofluorescence, tissue staining, flow cytometry, and fluorescent ELISA. This guide connects the Cy3 Goat Anti-Human IgG (H+L) Antibody to antibody-characterization studies while emphasizing controls, instrument fit, and troubleshooting rather than overstating biological conclusions.
-
Hoechst 33258 for Tumor Mechanics Assays
2026-08-20
Hoechst 33258 is a bis-benzimide DNA stain that can provide nuclear context in live-cell studies of KRas transfer and tumor-cell mechanics. This article explains how to integrate its fluorescence with confocal, optical-tweezer, and cell-cycle workflows without mistaking a nuclear counterstain for a direct reporter of oncogenic transport.
-
Sphingosine-1-phosphate Signaling Workflows
2026-08-19
Build reproducible S1P assays for receptor-proximal signaling, endothelial behavior, and neuronal apoptosis. This practical guide connects concentration control and orthogonal readouts with the S1PR3–TNF-α–caspase-3 findings reported after intracerebral hemorrhage.
-
Fucoidan Downregulates Caveolin-1 in MCF-7
2026-08-19
A 2026 study in Algal Research identifies caveolin-1 downregulation as a previously underexplored component of fucoidan activity in MCF-7 breast cancer cells. By combining dose-response cytotoxicity, membrane integrity, clonogenic, migration, and protein-expression assays, the study links this marine polysaccharide to both reduced tumor-cell survival and impaired progression-related behavior.
-
CB-5083: A Practical p97 Inhibitor Workflow
2026-08-18
Build a mechanism-led workflow around CB-5083 to connect p97 inhibition with ubiquitin accumulation, unfolded protein response signaling, stress-granule dynamics, and cancer-cell vulnerability. The approach combines quantitative cell assays with translational guidance for multiple myeloma research and xenograft studies.
-
Aconitase Activity Colorimetric Assay Kit Guide
2026-08-18
The Aconitase Activity Colorimetric Assay Kit provides a rapid functional readout of aconitase within TCA cycle and oxidative-stress studies. This guide connects the assay to CD28–ARS2-driven T-cell metabolic flexibility while defining what the measurement can—and cannot—show.
-
CD44 Metabolic Rewiring in IDH-Mutant Leukemia
2026-08-17
Lyu and colleagues identify CD44 as a functional metabolic dependency in IDH-mutant leukemia, linking adhesion signaling to pentose phosphate pathway activity, NADPH production, and sustained R-2HG synthesis. The study suggests that combining mutant-IDH inhibition with CD44 blockade may address a metabolic requirement that helps leukemia cells maintain the oncometabolite state.
-
BBB Permeability Prediction and Lysosomal Trapping
2026-08-17
Hu et al. developed a high-throughput Transwell surrogate blood-brain barrier model using LLC-PK1-MOCK/MDR1 cells and incorporated bafilomycin A1 correction for lysosomal trapping. Its correlation with unbound brain-to-plasma distribution supports early CNS compound prioritization while clarifying the difference between passive diffusion, P-glycoprotein efflux, and intracellular sequestration.
-
Berberine Hydrochloride and the Gut–Bone Axis
2026-08-16
Berberine hydrochloride is moving beyond conventional metabolic and antibacterial research as a mechanistic probe of gut–bone communication. New preclinical evidence connects microbiota-derived butyrate, intestinal tuft cells, barrier repair, and osteoimmune balance, creating a disciplined framework for translational studies.
-
AP20187 and Senescent CAF Assay Design
2026-08-15
AP20187 is a chemical inducer of dimerization that can convert static stromal models into temporally controlled assays. This article connects AP20187-driven signaling with senescent CAF biology, emphasizing causal experiment design, assay controls, and translational limitations.
-
SEMA3E Drives Beige Fat Thermogenesis via β-Catenin
2026-08-14
The reference study identifies SEMA3E as a regulator of beige adipocyte differentiation and non-shivering thermogenesis in mice, connecting its activity to mitochondrial oxidative phosphorylation and Wnt/β-catenin signaling. Its combination of tissue-specific gene manipulation, transplantation, transcriptomics, and mitochondrial respiration assays provides a mechanistic framework for studying adipose remodeling, while leaving important questions about pathway directionality and human translation unresolved.
-
Lithium, Exosomal Wnt10a, and Bone Regeneration
2026-08-14
The reference study identifies an exosome-centered mechanism by which lithium enhances bone mesenchymal stem cell osteogenesis: MARK2-associated Rab11a/Rab11FIP1 trafficking increases exosomal Wnt10a delivery and activates β-catenin signaling. Its comparison of lithium-conditioned exosomes with control exosomes, followed by GelMA hydrogel testing, provides a mechanistic and biomaterials framework for improving bone repair.
-
Semaphorin Receptors Antagonize Wnt Signaling
2026-08-13
This preprint identifies Neuropilin and Plexin semaphorin receptors as previously unrecognized antagonists of Wnt signaling, acting downstream of Dishevelled to promote proteasome-dependent β-catenin destabilization. Its receptor-specific results provide a framework for separating GSK3/CK1-dependent regulation from broader pathway effects when designing Wnt-focused cell assays.